A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
Conditions:   Fistulizing Crohns Disease;   Perianal Crohns Disease Interventions:   Drug: Guselkumab;   Drug: Placebo Sponsor:   Janssen-Cilag Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials